Swiss National Bank Arbutus Biopharma Corp Transaction History
Swiss National Bank
- $146 Billion
- Q4 2024
A detailed history of Swiss National Bank transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Swiss National Bank holds 276,300 shares of ABUS stock, worth $944,946. This represents 0.0% of its overall portfolio holdings.
Number of Shares
276,300
Previous 276,300
-0.0%
Holding current value
$944,946
Previous $1.06 Million
15.05%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
165Shares Held
102MCall Options Held
649KPut Options Held
666K-
Morgan Stanley New York, NY22.6MShares$77.2 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.2MShares$45.3 Million22.74% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$39.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$30.7 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.74MShares$29.9 Million4.68% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $513M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...